Clinical trials: Hypotension and Shock

Septic Shock

Midodrine Use in Septic Shock

• Terminated
• Age: 18 to 89 years
• Phase 3
• Results posted

The investigators aim to perform a randomized, double-blind, placebo-controlled trial to investigate the efficacy of midodrine in decreasing time to IV vasopressor liberation in patients with septic shock.

Trial name

NCT03706053

Testing

Midodrine Hydrochloride

Where

United States

Volunteers

10 people, healthy volunteers welcome

Sponsor

University of Virginia